alendronate plus d3 sandoz 70 mg/140 microgram alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 iu) tablet b
dr reddys laboratories australia pty ltd - colecalciferol, quantity: 0.14 mg; alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg) - tablet, uncoated - excipient ingredients: gelatin; croscarmellose sodium; butylated hydroxytoluene; colloidal anhydrous silica; sucrose; magnesium stearate; microcrystalline cellulose; povidone; medium chain triglycerides - tradenames are indicated for the treatment of: ? osteoporosis* in select patients where vitamin d supplementation is recommended,* prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture
alendronate plus d3 and calcium sandoz alendronic acid (as sodium) 70 mg and colecalciferol 140 microgram tablet and calcium 500
dr reddys laboratories australia pty ltd - alendronate sodium,calcium carbonate,colecalciferol,microcrystalline cellulose -
reddymax plus d-cal alendronic acid (as sodium) 70 mg and colecalciferol 140 microgram tablet and calcium 500 mg tablet composit
dr reddys laboratories australia pty ltd - alendronate sodium,calcium carbonate,colecalciferol,microcrystalline cellulose -
alendronate plus d3 sandoz 70 mg/70 microgram alendronate (as sodium) and colecalciferol 70 mg/70 microgram (2800 iu) tablet bli
dr reddys laboratories australia pty ltd - alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg); colecalciferol, quantity: 0.07 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; povidone; gelatin; croscarmellose sodium; medium chain triglycerides; microcrystalline cellulose; magnesium stearate; sucrose; butylated hydroxytoluene - tradenames are indicated for the treatment of: ? osteoporosis* in select patients where vitamin d supplementation is recommended,* prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture
dronalen plus d-cal alendronic acid 70mg/colecalciferol 140 microgram tablet and 1250mg calcium carbonate tablet composite pack
merck sharp & dohme (australia) pty ltd - alendronate sodium,calcium carbonate,colecalciferol -
fosamax plus d-cal alendronic acid 70mg/colecalciferol 140 microgram tablet and 1250mg calcium carbonate tablet composite pack
merck sharp & dohme (australia) pty ltd - alendronate sodium,calcium carbonate,colecalciferol -
dronalen plus 70 mg/140 microgram alendronic acid 70 mg (as alendronate sodium) and colecalciferol 140 micrograms tablet blister
merck sharp & dohme (australia) pty ltd - alendronate sodium,colecalciferol -
alendronate plus d3 70 mg/140 ug apotex alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 iu) tablet blister
dr reddys laboratories australia pty ltd - colecalciferol, quantity: 0.14 mg; alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg) - tablet, uncoated - excipient ingredients: magnesium stearate; povidone; sucrose; butylated hydroxytoluene; croscarmellose sodium; microcrystalline cellulose; gelatin; medium chain triglycerides; colloidal anhydrous silica - alendronate plus d3 70 mg/140 microgram apotex are indicated for the treatment of: osteoporosis in select patients where vitamin d supplementation is recommended, prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture
pm nextg cal kids
pharmametics products a division of max biocare pty ltd - colecalciferol,hydroxyapatite,menaquinone 7 -
advance+ milk calcium plus vitamin d3
universal pharmaceuticals pty ltd - colecalciferol,hydroxyapatite -